Zydus Recalls Topiramate 200 mg Tablets Due to Foreign Tablet Presence
Zydus Pharmaceuticals is recalling Topiramate 200 mg tablets because 100 mg tablets were found mixed in the bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which indicates a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The presence of a different strength of the same medication is a labeling/packaging error that could lead to incorrect dosing, but it is not a Class I hazard involving serious injury or death.
Plain-English summary
Zydus Pharmaceuticals USA Inc. is recalling Topiramate 200 mg tablets, 60 tablet bottles, due to the presence of foreign tablets. The recall involves 14,568 bottles of the medication, which is a prescription-only drug manufactured by Cadila Healthcare Ltd. in Ahmedabad, India, and distributed by Zydus Pharmaceuticals USA Inc. in Pennington, NJ.
The reason for the recall is the presence of topiramate 100 mg tablets comingled with the 200 mg tablets. This means that some bottles may contain a mix of the two different strengths of the medication. The affected product is identified by Lot # MN9828 and has an expiration date of October 2015.
The recall is distributed nationwide in the U.S. Consumers who have this medication should check their bottles for the specific lot number and expiration date. If the product matches the recalled lot, they should stop using it and contact their healthcare provider or pharmacist for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- TOPIRAMATE (TOPIRAMATE)
- Brand
- TOPIRAMATE
- Manufacturer
- Zydus Pharmaceuticals USA Inc
- Category
- Drug — Prescription Medication
- Affected units
- 14,568
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: MN9828
- Expiry: Oct 2015.
UPCs (4)
- 0368382140142
- 0368382141149
- 0368382139146
- 0368382138149
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TOPIRAMATE
- LowTopiramate 50 mg tablets recalled due to discoloration
FDA (Drugs) · 2021-12-01
- ModerateGlenmark Recalls Topiramate Tablets Due to Off-Odor Complaints
FDA (Drugs) · 2013-05-22
Same manufacturer · Zydus Pharmaceuticals USA Inc
See all →- SevereFDA Recalls Mirabegron Tablets Over Nitrosamine Impurity
FDA (Drugs) · 2026-08-12
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- HighIcosapent ethyl capsules recalled after active ingredient oxidized inside capsule
FDA (Drugs) · 2026-03-18
- HighIcosapent ethyl capsules recalled as subpotent after capsule contents leaked
FDA (Drugs) · 2026-01-28
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02